# Non-Invasive Screening for Fetal Aneuploidy

> **NCT00847990** · — · COMPLETED · sponsor: **Sequenom, Inc.** · enrollment: 5000 (estimated)

## Conditions studied

- Down Syndrome
- Edwards Syndrome

## Interventions

- **OTHER:** Maternal blood screening test for fetal aneuploidy

## Key facts

- **NCT ID:** NCT00847990
- **Lead sponsor:** Sequenom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2011-04
- **Final completion:** 2011-08
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2011-09-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847990, "Non-Invasive Screening for Fetal Aneuploidy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00847990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*